HDP-101

· Heidelberg Pharma AG

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for HDP-101, covering 2024-07-24 to 2026-04-14. Get the full timeline:

Most recent: Clinical Trial Update: Study to Assess Safety and Efficacy of HDP-101 in Chinese Patients With Relapsed or Refractory Multiple Myeloma [Phase 1]

See pricing